Breast cancer is the second most reported cancer in women with high mortality causing
millions of cancer-related deaths annually. Early detection of breast cancer intensifies the …

Among cancers, breast cancer has the highest incidence rate among women and poses a
tremendous threat to women's health. Messenger RNA (mRNA), microRNA (miRNA) and …

Breast cancer is one of the most common cancers with the highest morbidity and mortality
among women despite the treatment approaches have advanced including surgery …

Our understanding of breast cancer and its therapeutic approach has improved greatly due
to the advancement of molecular biology in recent years. Clinically, breast cancers are …

Multi-drug resistance is one of the major obstacles in the treatment of cancers. This
undesirable feature increases the mortality rate of cancers, including breast cancer …

Triple-negative breast cancer (TNBC), which is the most malignant subtype of breast cancer
(BC), accounts for 10%–20% of all BC cases. TNBC, which occurs more frequently in young …

Breast cancer has surpassed lung cancer to become the most common malignancy
worldwide. The incidence rate and mortality rate of breast cancer continue to rise, which …

Estrogen Receptor is the driving transcription factor in about 75% of all breast cancers,
which is the target of endocrine therapies, but drug resistance is a common clinical problem …

Due to the high heterogeneity and initially asymptomatic nature of breast cancer (BC), the
management of this disease depends on imaging together with immunohistochemical and …

Circular RNAs (circRNAs) are a class of long, non-coding RNAs molecules that shape a
covalently closed continuous loop which have no 5′–3′ polarity and contain no polyA tail …